儿童与成人毛细胞型星形细胞瘤的临床与基因组差异
单中心回顾性研究纳入2000至2023年活检或切除的334例儿童与32例成人毛细胞型星形细胞瘤(PA)患者,比较临床特征、肿瘤基因组与无进展/复发生存(PRFS)。儿童KIAA1549::BRAF融合更常见、全切率更高,儿童全切与小脑部位均与更低进展/复发率及更长PRFS相关;成人未发现手术或基因组预测因素,两组总体进展/复发率无差异。
要点
- 儿童PA中KIAA1549::BRAF融合更常见(59.6%对23.1%),BRAF p.V600E在两组均少见。
- 儿童全切率高于成人(79.1%对62.1%),且全切与更低进展/复发率和更长PRFS相关。
- 成人PA未发现与PRFS相关的手术或基因组预测因素,需个体化随访。
核心结论
- 儿童与成人PA的临床特征及影响肿瘤进展/复发的因素不同,年龄相关差异仍存在知识空白。
研究设计与样本
- 单中心回顾性研究,纳入2000至2023年接受活检或切除的PA患者,共334例儿童和32例成人,收集临床数据与肿瘤基因组并分析PRFS。
主要发现
- 肿瘤部位分布两组无差异,小脑为最主要部位(儿童59.3%、成人50.0%)。
- 儿童全切更常见(79.1%对62.1%,p=0.04),KIAA1549::BRAF融合更频繁(59.6%对23.1%,p=0.02)。
- 儿童全切者肿瘤进展/复发率更低(9.8%对41.2%,p<0.001)且PRFS更长(p<0.001)。
- 儿童小脑肿瘤进展/复发率更低(13.1%对31.6%,p<0.001)且PRFS更长(p<0.001)。
- 总体进展/复发率两组无差异(儿童21.3%对成人15.6%,p=0.65)。
关键数值与推荐
- 儿童全切率79.1%、成人62.1%(p=0.04)。
- 儿童KIAA1549::BRAF融合59.6%、成人23.1%(p=0.02)。
- BRAF p.V600E儿童14.6%、成人8.3%(p=1)。
临床怎么用
- 儿童PA应争取全切,全切与小脑部位均与更低进展/复发风险相关。
- 成人PA缺乏明确手术或基因组预后因素,术后随访策略需个体化。
局限性
- 为单中心回顾性研究,成人样本量仅32例,结论推广需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Pilocytic astrocytoma (PA) is rare in adults despite being the most common pediatric brain tumor. KIAA1549::BRAF fusion and BRAF p.V600E mutation are common in PA, yet prognostic impact of these alterations remains uncertain. We highlight clinical characteristics and tumor genomics in PA across the lifespan, exploring factors associated with disease progression. METHODS: Pediatric and adult patients who underwent biopsy or resection of PA from 2000 to 2023 were retrospectively studied. Clinical data and tumor genomics were collected, and progression/recurrence-free survival (PRFS) analysis was performed. RESULTS: We identified 334 pediatric and 32 adult PA patients. Tumor location distribution did not differ between groups, with the cerebellum being the predominant location (59.3% pediatric and 50.0% adult). Gross total resection (GTR) was more common in children (79.1% versus 62.1%, p = 0.04). KIAA1549::BRAF fusion was more frequent in children (59.6% versus 23.1%, p = 0.02). BRAF p.V600E mutations were rarer in both groups (14.6% pediatric versus 8.3% adult, p = 1). In children, GTR was associated lower rates of tumor progression/recurrence (9.8% versus 41.2%, p < 0.001) and longer PRFS (p < 0.001). Cerebellar tumors in children were also associated with lower rates of tumor progression/recurrence (13.1% versus 31.6%, p < 0.001) and longer PRFS (p < 0.001). No operative/genomic predictors of PRFS were identified in adults. Overall rate of tumor progression/recurrence did not differ between groups (21.3% pediatric versus 15.6% adult, p = 0.65). CONCLUSION: Clinical characteristics and factors influencing tumor progression/recurrence differ in children and adults with PA. This work highlights current knowledge gaps on age-related differences in PA, providing clinical and genomic context for future studies.
引用
- Chandler KE, Grigorian JN, Pisharody VA, et al. Clinical and genomic factors differ in pediatric and adult pilocytic astrocytoma: a single-center experience with over 350 patients. J Neurooncol. 2025. PMID: 40775485. doi:10.1007/s11060-025-05145-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。